Ratings by Needham (Gil Blum)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/28/2024 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
3/28/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
3/20/2024 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
3/18/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
3/15/2024 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
3/7/2024 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
2/29/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
2/29/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
2/28/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Buy (N/A) |
|
Details | ||
2/13/2024 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
2/12/2024 | Autolus Therapeutics plc | AUTL | Maintain | Buy (N/A) |
|
Details | ||
2/8/2024 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
1/4/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
12/11/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
11/15/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
11/7/2023 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
11/2/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
9/25/2023 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
9/13/2023 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
9/13/2023 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
54.02 (57.41) |
6.28% | Details | |
8/11/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
5/15/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
5/10/2023 | CTI BioPharma | CTIC | Downgrade | Hold (Buy) |
4.82 (9.09) |
88.59% | Details | |
5/9/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
3/17/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
3/16/2023 | Recursion Pharmaceuticals | RXRX | New Coverage | Buy (N/A) |
7.48 (7.92) |
5.88% | Details | |
3/1/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
2/24/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
2/24/2023 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
2/22/2023 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
2/13/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
2/10/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
1/10/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
1/3/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
12/12/2022 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
11/4/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
10/27/2022 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
20.27 (53.25) |
162.7% | Details | |
7/28/2022 | Nkarta Inc. | NKTX | New Coverage | Buy (N/A) |
12.84 (7.08) |
-44.86% | Details | |
7/28/2022 | Fate Therapeutics | FATE | New Coverage | Hold (N/A) |
33.17 (4.31) |
-87.01% | Details | |
7/11/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
7/7/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
6/24/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
6/14/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
6/6/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
6/6/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
6/2/2022 | Aeglea Biotherapeutics | AGLE | Downgrade | Hold (Buy) |
1.50 (12.01) |
700.67% | Details | |
5/26/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
5/17/2022 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
5/17/2022 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
5/17/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
5/13/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
5/13/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
5/10/2022 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
5/6/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (Buy) |
|
Details | ||
5/6/2022 | Generation Bio | GBIO | Maintain | Buy (Buy) |
|
Details | ||
5/5/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
5/5/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
5/5/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
5/4/2022 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
4/18/2022 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
4/18/2022 | Autolus Therapeutics plc | AUTL | Maintain | Buy (Buy) |
|
Details | ||
4/14/2022 | G1 Therapeutics | GTHX | Maintain | Buy (Buy) |
|
Details | ||
4/14/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Shattuck Labs | STTK | Maintain | Buy (Buy) |
|
Details | ||
4/12/2022 | Generation Bio | GBIO | Maintain | Buy (Buy) |
|
Details | ||
4/6/2022 | Genocea Biosciences | GNCA | Maintain | Buy (Buy) |
|
Details | ||
3/31/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
3/29/2022 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
3/24/2022 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
3/17/2022 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
3/16/2022 | Athersys | ATHX | Maintain | Buy (Buy) |
|
Details | ||
3/15/2022 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
3/14/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (Buy) |
|
Details | ||
3/11/2022 | Geron Corporation | GERN | Maintain | Buy (Buy) |
|
Details | ||
3/10/2022 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
3/10/2022 | Autolus Therapeutics plc | AUTL | Maintain | Buy (Buy) |
|
Details | ||
3/2/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
3/1/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
2/4/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (Buy) |
|
Details | ||
2/3/2022 | Athersys | ATHX | Maintain | Buy (Buy) |
|
Details | ||
1/28/2022 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
1/4/2022 | Avrobio Inc. | AVRO | Maintain | Buy (N/A) |
|
Details | ||
12/15/2021 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
12/1/2021 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
11/15/2021 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
10/5/2021 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
7/16/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
20.50 (2.37) |
-88.44% | Details | |
5/27/2021 | Amicus Therapeutics | FOLD | New Coverage | Hold (N/A) |
9.00 (10.55) |
17.22% | Details | |
5/27/2021 | Avrobio Inc. | AVRO | New Coverage | Buy (N/A) |
8.05 (1.21) |
-84.97% | Details | |
2/18/2021 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
52.62 (23.47) |
-55.4% | Details | |
2/18/2021 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
31.79 (3.00) |
-90.56% | Details |